Journal
CHEMISTRY & BIODIVERSITY
Volume 6, Issue 2, Pages 231-243Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cbdv.200800019
Keywords
-
Ask authors/readers for more resources
The 30% EtOH extracts of Ganoderma lucidum FR. KARST (Ganodermateceae) showed weak 5 alpha-reductase inhibitory activity and binding ability to androgen receptor. When LNCaP (lymph-node carcinoma of the prostate) cells were treated with the EtOH extracts, cell proliferation was inhibited. Treatment with the extracts significantly inhibited the testosterone-induced growth of the ventral prostate in castrated rats. These results showed that G. lucidum might be a useful ingredient in the treatment of androgen-induced diseases, such as benign prostatic hyperplasia or prostate cancer. From the 30% EtOH extracts, we isolated ganoderiol F, which showed binding activity to androgen receptor and inhibited LNCaP cell proliferation, as one of the active compounds in the 30% EtOH extracts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available